Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)
Clinical trial NCT02535104 · COMPLETED
Trial details
- NCT number
- NCT02535104
- Sponsor
- Tamir Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-09-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.